Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Explore the 2026 LCA landscape for cobalt, lithium, and nickel battery supply chains — methodologies, environmental impact modeling, and patent intelligence.
Article | Report How engineers use patent citation mapping to identify seminal inventions in emerging tech. Covers forward & backward citation analysis, network methods, and R&D strategy.
Article | Report Gefurulimab and AstraZeneca's C5 complement inhibitor enter Phase II/III in myasthenia gravis. How do they compare to efgartigimod and ravulizumab?
Article | Report Explore the 2026 nanocellulose composite materials landscape for packaging and structural applications — patent trends, key players, and innovation intelligence.
Article | Report AEMWE patent and literature landscape 2026: membrane chemistry, non-PGM catalysts, scale-up milestones, and strategic IP white space for green hydrogen.
Article | Report Giredestrant (GDC-9545) enters Phase III in early HR+ breast cancer via Roche's evERA trial. Analyse the oral SERD competitive landscape: imlunestrant, camizestrant, elacestrant & more.
Article | Report How AI is transforming systematic literature review for technology platform development — faster screening, smarter synthesis, and patent-aware R&D workflows.
Article | Report Explore the 2026 copper alloy materials landscape for EV motor windings and power connectors. Key IP spaces, technology gaps, and dominant material strategies.
Article | Report A deep analysis of edge AI inference accelerator technology in 2026: dedicated silicon, FPGA, PIM architectures, NAS, and distributed inference across 80+ patent and literature records.
Article | Report Fenebrutinib vs. tolebrutinib: how CNS-penetrant BTK inhibitors target smoldering lesions and microglia in progressive MS. Phase III data signals analysed.
Article | Report The 2026 nickel superalloy landscape for gas turbine blades and additive manufacturing: key data sources, research gaps, and how to retrieve patent intelligence.
Article | Report TGA vs DSC for polymer degradation: understand which thermal analysis technique reveals mass loss, heat flow, or transition data—and when to use both together.
Article | Report Monopile foundations dominate 80% of offshore wind capacity. Explore the 2026 technology landscape: PISA models, TP-less designs, XXL monopiles, and key patents.
Article | Report Explore the key technical barriers to cost-competitive direct lithium extraction (DLE) from geothermal brine, from ion selectivity to scaling challenges.
Article | Report Dostarlimab (Jemperli) PD-1 inhibitor Phase III expansion in dMMR endometrial and colorectal cancer: GSK's biomarker-driven immunotherapy strategy explained.